Phase 4 Preserved Ejection Fraction Clinical Trials
7 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–7 of 7 trials
Recruiting
Phase 4
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
Iron-deficiencyHeart Failure With Preserved Ejection Fraction
Massachusetts General Hospital66 enrolled1 locationNCT04945707
Recruiting
Phase 4
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
Type 2 Diabetes Mellitus in ObeseHeart Failure With Preserved Ejection Fraction
The University of Texas Health Science Center at San Antonio78 enrolled1 locationNCT05838287
Recruiting
Phase 4
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
End Stage Renal Disease on DialysisHeart Failure With Preserved Ejection Fraction
National Taiwan University Hospital150 enrolled2 locationsNCT06249945
Recruiting
Phase 4
Use of SGLT2i in noHCM With HFpEF
Hypertrophic CardiomyopathyHeart Failure With Preserved Ejection Fraction
China National Center for Cardiovascular Diseases94 enrolled1 locationNCT06401343
Recruiting
Phase 4
CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction
Atrial FibrillationHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Charite University, Berlin, Germany1,548 enrolled1 locationNCT05508256
Completed
Phase 4
Evaluating Testosterone Therapy to Prevent Heart Failure in Women: The ETHEL study.
Stage B heart failure with preserved ejection fraction
Monash University38 enrolled1 locationACTRN12623000165684
Completed
Phase 3Phase 4
Use of exercise and medical therapies to improve cardiac function among patients with exertional shortness of breath due to lung congestion
Diastolic dysfunction, heart failure with preserved ejection fraction (HFpEF)
University of Queensland150 enrolled1 locationACTRN12610001087044